Bausch Health (BHC) Companies announced the commercial expansion of OraPharma into Canada and Puerto Rico. This strategic move reflects OraPharma’s commitment to improving oral health awareness, providing access to treatments within periodontal disease management, and strengthening partnerships with local distributors and dental professionals in these markets.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Closing Bell Movers: Meta sinks, Alphabet jumps after earnings
- Bausch Health reports Q3 revenue $2.68B, consensus $2.63B
- Bausch Health sees FY25 revenue $10.05B-$10.25B, consensus $10.12B
- Bausch Health options imply 8.2% move in share price post-earnings
- Midday Fly By: Nvidia hits $5T market cap, Boeing takes big 777X charge